Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAF V600 wild-type melanoma progressing on prior anti–programmed death-1 therapy
Title:
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAF V600 wild-type melanoma progressing on prior anti–programmed death-1 therapy
Author:
Sandhu, Shahneen Atkinson, Victoria Cao, Maria González Medina, Theresa Rivas, Ainara Soria Menzies, Alexander M. Caro, Ivor Roberts, Louise Song, Yuyao Yan, Yibing Guo, Yu Xue, Cloris Long, Georgina V.